Synaptic plasticity alterations associated with memory impairment induced by deletion of CB2 cannabinoid receptors

Neuropharmacology

Volumn 73, Issue , 2013, Pages 388-396

  García Gutiérrez, María S ^a,d   Ortega Álvaro, Antonio ^b,c   Busquets García, Arnau ^c   Pérez Ortiz, Jose M ^b   Caltana, Laura ^e   Ricatti, María Jimena ^e   Brusco, Alicia ^e   Maldonado, Rafael ^c   Manzanares, Jorge ^a,d  

^a MIGUEL HERNÁNDEZ UNIVERSITY   (Spain)

^b HOSPITAL GENERAL UNIVERSITARIO DE ALBACETE   (Spain)

^c UNIVERSITAT POMPEU FABRA   (Spain)

^d INSTITUTO DE SALUD CARLOS III   (Spain)

^e Facultad de Medicina   (Argentina)

Author keywords

Immunohistochemistry; Memory; Rt PCR

Indexed keywords

1 DEOXY 3 (1,1 DIMETHYLBUTYL) DELTA8 TETRAHYDROCANNABINOL; 6 IODO 3 (4 METHOXYBENZOYL) 2 METHYL 1 (2 MORPHOLINOETHYL)INDOLE; BRAIN DERIVED NEUROTROPHIC FACTOR; CANNABINOID 2 RECEPTOR; GLUCOCORTICOID RECEPTOR; MAMMALIAN TARGET OF RAPAMYCIN; MICROTUBULE ASSOCIATED PROTEIN 2; NEUROFILAMENT PROTEIN; PROTEIN KINASE B; SYNAPTOPHYSIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BDNF GENE; CB2 GENE; CONTROLLED STUDY; DENTATE GYRUS; DOSE RESPONSE; ELECTRON MICROSCOPY; GENE; GENE DELETION; GENE EXPRESSION; GENOTYPE; HIPPOCAMPAL CA1 REGION; HIPPOCAMPUS; IMMUNOREACTIVITY; MALE; MAP2 GENE; MEMORY CONSOLIDATION; MEMORY DISORDER; MOUSE; NERVE CELL PLASTICITY; NEUROLOGIC EXAMINATION; NF200 GENE; NONHUMAN; NR3C1 GENE; POSTSYNAPTIC DENSITY; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; STEP DOWN INHIBITORY AVOIDANCE TEST; SYN GENE; SYNAPSE; SYNAPSE DISTANCE;

CANNABINOID CB(2)R-AGONIST JWH133; CB(2)R; IMMUNOHISTOCHEMISTRY; MEMORY; MICE LACKING CB(2)R; RT-PCR;

ANIMALS; AVOIDANCE LEARNING; BRAIN-DERIVED NEUROTROPHIC FACTOR; CANNABINOID RECEPTOR AGONISTS; CANNABINOID RECEPTOR ANTAGONISTS; CANNABINOIDS; GENE EXPRESSION; HIPPOCAMPUS; INDOLES; MEMORY; MEMORY DISORDERS; MICE; MICE, KNOCKOUT; MICROTUBULE-ASSOCIATED PROTEINS; NEUROFILAMENT PROTEINS; NEURONAL PLASTICITY; PREFRONTAL CORTEX; RECEPTOR, CANNABINOID, CB2; RECEPTORS, GLUCOCORTICOID; RIBOSOMAL PROTEIN S6 KINASES, 70-KDA; SIGNAL TRANSDUCTION; SYNAPSES; SYNAPTOPHYSIN; TOR SERINE-THREONINE KINASES;

EID: 84885134675     PISSN: 00283908     EISSN: 18737064     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2013.05.034     Document Type: Article

References (55)

1. 2 receptors. Neuropsychopharmacology 37, 1749-1763.
2. Atwood, B.K., Mackie, K., 2010. CB2: a cannabinoid receptor with an identity crisis. Br. J. Pharmacol. 160, 467-479.
3. Baek, J.H., Darlington, C.L., Smith, P.F., Ashton, J.C., 2013. Antibody testing for brain immunohistochemistry: brain immunolabeling for the cannabinoid CB2 receptor. J. Neurosci. Methods 216 (2), 87-95.
4. Bekinschtein, P., Cammarota, M., Igaz, L.M., et al, 2007. Persistence of long-term memory storage requires a late protein synthesis- and BDNF-dependent phase in the hippocampus. Neuron 53, 261-277.
5. Breivogel, C.S., Griffin, G., Di Marzo, V., Martin, B.R., 2001. Evidence for a new G protein-coupled cannabinoid receptor in mouse brain. Mol. Pharmacol. 60, 155-163.
6. 2) brain injection. Neurotox. Res. 15, 348-358.
7. Cazakoff, B.N., Howland, J.G., 2010. Acute stress disrupts paired pulse facilitation and long-term potentiation in rat dorsal hippocampus through activation of glucocorticoid receptors. Hippocampus 20, 1327-1331.
8. Choi, I.-Y., Ju, C., Anthony Jalin, M.A., Lee, D.I., Prather, P.L., et al., 2013. Activation of cannabinoid CB2 receptors mediated AMPK/CREB pathway reduces cerebral ischemic injury. Am. J. Pathol. 182, 928-939.
9. Costanzi, M., Battaglia, M., Rossi-Arnaud, C., Cestari, V., Castellano, C., 2004. Effects of anandamide and morphine combinationson memory consolidation incd1 mice: involvementofdopaminergic mechanisms. Neurobiol. Learn. Mem. 81, 144-149.
10. Da, S., Takahashi, R.N., 2002. SR 141716A prevents delta 9-tetrahydrocannabinol-induced spatial learning deficit in a Morris-type water maze in mice. Prog. Neuropsychopharmacol. Biol. Psychiatry 26, 321-325.
11. Dehmelt, L., Halpain, S., 2005. The MAP2/Tau family of microtubule-associated proteins. Genome Biol. 6, 204.
12. Den Boon, F.S., Chameau, P., Schaafsma-Zhao, Q., van Aken, W., Bari, M., Oddi, S., et al, 2012. Excitability of prefrontal cortical pyramidal neurons is modulated by activation of intracellular type-2 cannabinoid receptors. Proc. Natl. Acad. Sci. U. S. A. 109 (9), 3534-3539.
13. Fanara, P., Husted, K.H., Selle, K., Wong, P.Y., Banerjee, J., Brandt, R., et al, 2010. Changes in microtubule turnover accompany synaptic plasticity and memory formation in response to contextual fear conditioning in mice. Neuroscience 168, 167-178.
14. Franklin, J.M., Carrasco, G.A., 2013. Cannabinoid receptor agonists upregulate and enhance serotonin 2A (5-HT(2A)) receptor activity via ERK1/2 signaling. Synapse 67 (3), 145-159.
15. García-Gutiérrez, M.S., Manzanares, J., 2011. Overexpression of CB2 cannabinoid receptors decreased vulnerability to anxiety and impaired anxiolytic action of alprazolam in mice. J. Psychopharmacol. 25, 111-120.
16. García-Gutiérrez, M.S., Pérez-Ortiz, J.M., Gutiérrez-Adán, A., Manzanares, J., 2010. Depression-resistant endophenotype in mice overexpressing cannabinoid CB(2) receptors. Br. J. Pharmacol. 160, 1773-1784.
17. Gong, J.P., Onaivi, E.S., Ishiguro, H., Liu, Q.R., Tagliaferro, P.A., Brusco, A., et al, 2006. Cannabinoid CB2 receptors: immunohistochemical localization in rat brain. Brain Res. 1071, 10-23.
18. Griffin, G., Wray, E.J., Tao, Q., McAllister, S.D., Rorrer, W.K., Aung, M.M., Martin, B.R., Abood, M.E., 1999. Evaluation of the cannabinoid CB2 receptor-selective antagonist, SR144528: further evidence for cannabinoid CB2 receptor absence in the rat central nervous system. Eur. J. Pharmacol. 377 (1), 117-125.
19. Hajos, N., Ledent, C., Freund, T.F., 2001. Novel cannabinoid-sensitive receptor mediates inhibition of glutamatergic synaptic transmission in the hippocampus. Neuroscience 106, 1-4.
20. Herkenham, M., Lynn, A.B., Johnson, M.R., Melvin, L.S., de Costa, B.R., Rice, K.C., 1991. Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study. J. Neurosci. 11, 563-583.
21. Huang, E.J., Reichardt, L.F., 2001. Neurotrophins: roles in neuronal development and function. Annu. Rev. Neurosci. 24, 677-736.
22. Huffman, J.W., Liddle, J., Yu, S., Aung, M.M., Abood, M.E., Wiley, J.L., et al, 1999. 3-(1',1 '-Dimethylbutyl)-1-deoxy-delta8-THC and related compounds: synthesis of selective ligands for the CB2 receptor. Bioorg. Med. Chem. 7, 2905-2914.
23. Kofalvi, A., Vizi, E.S., Ledent, C., Sperlagh, B., 2003. Cannabinoids inhibit the release of [3H]glutamate from rodent hippocampal synaptosomes via a novel CB1 receptor-independent action. Eur. J. Neurosci. 18, 1973-1978.
24. Korte, M., Carroll, P., Wolf, E., Brem, G., Thoenen, H., Bonhoeffer, T., 1995. Hippocampal long-term potentiation is impaired in mice lacking brain-derived neurotrophic factor. Proc. Natl. Acad. Sci. U. S. A. 92, 8856-8860.
25. Lehman, J.A., Calvo, V., Gomez-Cambronero, J., 2003. Mechanism of ribosomal p70S6 kinase activation by granulocyte macrophage colony-stimulating factor in neutrophils: cooperationofa MEK-related, THR421/SER424 kinase and a rapamycin-sensitive, m-TOR-related THR389 kinase. J. Biol. Chem. 278, 28130-28138.
26. Livak, K.J., Schmittgen, T.D., 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25, 402-408.
27. Ma, Y.L., Wang, H.L., Wu, H.C., Wei, C.L., Lee, E.H., 1998. Brain-derived neurotrophic factor antisense oligonucleotide impairs memory retention and inhibits longterm potentiation in rats. Neuroscience 82, 957-967.
28. Masliah, E., Mallory, M., Hansen, L., DeTeresa, R., Alford, M., Terry, R., 1994. Synaptic and neuritic alterations during the progression of Alzheimer's disease. Neurosci. Lett. 174, 67-72.
29. Mishima, K., Egashira, N., Hirosawa, N., Fujii, M., Matsumoto, Y., Iwasaki, K., et al, 2001. Characteristics of learning and memory impairment induced by delta9-tetrahydrocannabinol in rats. Jpn. J. Pharmacol. 87, 297-308.
30. Morgan, N.H., Stanford, I.M., Woodhall, G.L., 2009. Functional CB2 type cannabinoid receptors at CNS synapses. Neuropharmacology 57, 356-368.
31. Onaivi, E.S., 2006. Neuropsychobiological evidence for the functional presence and expression of cannabinoid CB2 receptors in the brain. Neuropsychobiology 54, 231-246.
32. Onaivi, E.S., Ishiguro, H., Gong, J.P., Patel, S., Meozzi, P.A., Myers, L., et al, 2008. Brain neuronal CB2 cannabinoid receptors in drug abuse and depression: from mice to human subjects. PLoS ONE 3, e1640.
33. Ortega-Álvaro, A., Aracil-Fernández, A., García-Gutiérrez, M.S., Navarrete, F., Manzanares, J., 2011. Deletion of CB2 cannabinoid receptor induces schizophrenia-related behaviors in mice. Neuropsychopharmacology 36, 1489-1504.
34. Palkovits, M., 1983. Punch sampling biopsy technique. Methods Enzymol. 103, 368-376.
35. Pamplona, F.A., Takahashi, R.N., 2006. WIN 55212-2 impairs contextual fear conditioning through the activation of CB1 cannabinoid receptors. Neurosci. Lett. 397, 88-92.
36. Paxinos, G., Franklin, K.B.J., 2001. The Mouse Brain in Stereotaxic Coordinates. Academic Press. Harcourt Science and Technology Company, New York.
37. Penzes, P., Srivastava, D.P., Woolfrey, K.M., 2009. Not just actin? A role for dynamic microtubules in dendritic spines. Neuron 61, 3-5.
38. Pertwee, R., Griffin, G., Fernando, S., Li, X., Hill, A., Makriyannis, A., 1995. AM630, a competitive cannabinoid receptor antagonist. Life Sci. 56, 1949-1955.
39. Puighermanal, E., Marsicano, G., Büsquets-García, A., Lutz, B., Maldonado, R., Ozaita, A., 2009. Cannabinoid modulation of hippocampal long-term memory is mediated by mTOR signaling. Nat. Neurosci. 12, 1152-1158.
40. Reynolds, E.S., 1963. The use of lead citrate at high pH as an electron-opaque stain in electron microscopy. J. Cell. Biol. 17, 208-212.
41. Richter, J.D., Klann, E., 2009. Making synaptic plasticity and memory last: mechanisms of translational regulation. Genes Dev. 23, 1-11.
42. Riedel, G., Davies, S.N., 2005. Cannabinoid function in learning, memory and plasticity. Handb. Exp. Pharmacol., 445-477.
43. Scheff, S.W., Price, D.A., Schmitt, F.A., DeKosky, S.T., Mufson, E.J., 2007. Synaptic alterations in CA1 in mild Alzheimer disease and mild cognitive impairment. Neurology 68, 1501-1508.
44. Smith, M.A., Makino, S., Kvetnansky, R., Post, R.M., 1995. Stress and glucocorticoids affect the expression of brain-derived neurotrophic factor and neurotrophin-3 mRNAs in the hippocampus. J. Neurosci. 15, 1768-1777.
45. Sutton, M.A., Schuman, E.M., 2005. Local translational control in dendrites and its role in long-term synaptic plasticity. J. Neurobiol. 64, 116-131.
46. Tagliaferro, P., Javier Ramos, A., Onaivi, E.S., Evrard, S.G., Lujilde, J., Brusco, A., 2006. Neuronal cytoskeleton and synaptic densities are altered after a chronic treatment with the cannabinoid receptor agonist WIN 55, 212-2. Brain Res. 1085, 163-176.
47. Takei, N., Kawamura, M., Hara, K., et al, 2001. Brain-derived neurotrophic factor enhances neuronal translation by activating multiple initiation processes: comparison with the effects of insulin. J. Biol. Chem. 276, 42818-42825.
48. Takei, N., Inamura, N., Kawamura, M., et al, 2004. Brain-derived neurotrophic factor induces mammalian target of rapamycin-dependent local activation of translation machinery and protein synthesis in neuronal dendrites. J. Neurosci. 24, 9760-9769.
49. Tanaka, J., Horiike, Y., Matsuzaki, M., et al, 2008. Protein synthesis and neurotrophin-dependent structural plasticity of single dendritic spines. Science 319, 1683-1687.
50. Thiemann, G., Fletcher, B.C., Ledent, C., Molleman, A., Hasenohrl, R.U., 2007. The genetic versus pharmacological invalidation of the cannabinoid CB(1) receptor results in differential effects on 'non-associative' memory and forebrain monoamine concentrations in mice. Neurobiol. Learn. Mem. 88, 416-423.
51. Urigüen, L., Pérez-Rial, S., Ledent, C., Palomo, T., Manzanares, J., 2004. Impaired action of anxiolytic drugs in mice deficient in cannabinoid CB1 receptors. Neuropharmacology 46, 966-973.
52. Van Sickle, M.D., Duncan, M., Kingsley, P.J., Mouihate, A., Urbani, P., Mackie, K., et al, 2005. Identification and functional characterization of brainstem cannabinoid CB2 receptors. Science 310 (5746), 329-332.
53. Wu, J., Bie, B., Yang, H., Xu, J.J., Brown, D.L., Naguib, M., 2012. Activation of the CB(2) receptor system reverses amyloid-induced memory deficiency. Neurobiol. Aging 34 (3), 791-804.
54. Xi, Z.X., Peng, X.Q., Li, X., Song, R., Zhang, H.Y., Liu, Q.R., et al, 2011. Brain cannabinoid CB(2) receptors modulate cocaine's actions in mice. Nat. Neurosci. 14, 1160-1166.
55. Zhou, X., Lin, D., Zheng, F., et al, 2010. Intracellular calcium and calmodulin link brain-derived neurotrophic factor to p70S6 kinases phosphorylation and dendritic protein synthesis. J. Neurosci. Res. 88, 1420-1432.